Novo Nordisk stock (NVO) jumped more than 2% in trading Wednesday after beating Wall Street's profit estimates for the first quarter and despite a slight cut to its sales forecast for the year.

[COPENHAGEN] Obesity drugmaker Novo Nordisk said on Wednesday (May 7) it would drop gender representation requirements for its US business following executive orders by President Donald Trump to stop ...

GLP-1 drugmaker Novo Nordisk's (NYSE: NVO) stock jumped at the open and remains up 3.2% as of 10:20 a.m. ET after the company reported earnings this morning. Novo reported smaller-than-expected Q1 ...

Caremark negotiated an undisclosed lower net price for Wegovy over Zepbound on its standard formularies, offering savings on Novo Nordisk's drug to clients that opt into those plans. But ...

Novo Nordisk stock reported strong sales growth but lowered sales forecasts this morning. The good news: 2025 earnings will grow faster than sales. Novo Nordisk reports its results in Danish ...

With its Q1 2025 results on Wednesday, Novo Nordisk (NVO) lowered its full-year outlook, but its shares were rising in European trading after the pharma giant projected a sales recovery for its ...

Q1 Wegovy sales rose 85% to DKK 17.36 billion; Ozempic up 18% to DKK 32.72 billion. Novo Nordisk's Q1 sales hit $10.89 billion, missing the $11.64 billion consensus estimate. Don’t miss this ...

Shares of Novo Nordisk jumped nearly 7% on Wednesday after it said sales of its blockbuster Wegovy weight loss drug were seen improving in the second half of the year as the availability of ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks on Jim Cramer’s radar. On Friday, Mad Money host Jim Cramer discussed this week’s ...